Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
302
-
Total 13F shares, excl. options
-
207M
-
Shares change
-
+7.24M
-
Total reported value, excl. options
-
$4.14B
-
Value change
-
+$165M
-
Put/Call ratio
-
0.1
-
Number of buys
-
190
-
Number of sells
-
-132
-
Price
-
$19.99
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q3 2024
347 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q3 2024.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 302 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 207M shares
of 237M outstanding shares and own 87.56% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (38.3M shares), VANGUARD GROUP INC (18.1M shares), STATE STREET CORP (13M shares), Invesco Ltd. (12.6M shares), MORGAN STANLEY (8.6M shares), Nuveen Asset Management, LLC (6.58M shares), GEODE CAPITAL MANAGEMENT, LLC (5.38M shares), D. E. Shaw & Co., Inc. (5.26M shares), TWO SIGMA ADVISERS, LP (4.45M shares), and AWM Investment Company, Inc. (4.45M shares).
This table shows the top 302 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.